Wolverine Trading’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Wolverine Trading’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,010	Closed	-$40.6K	–	5519
2023 Q4	$40.6K	Sell	3,010 -280	-9%	-$4.54K	﹤0.01%	4300
2023 Q3	$71.4K	Hold	3,290	–	–	﹤0.01%	4096
2023 Q2	$128K	Sell	3,290 -200	-6%	-$7.05K	﹤0.01%	3687
2023 Q1	$93K	Buy	+3,490	New	+$118K	﹤0.01%	3685
2022 Q4	–	Sell	-429	Closed	-$53K	–	5431
2022 Q3	$53K	Sell	429 -446	-51%	-$80.3K	﹤0.01%	4127
2022 Q2	$151K	Buy	+875	New	+$184K	﹤0.01%	3678
2022 Q1	–	Sell	-1,412	Closed	-$752K	–	6860
2021 Q4	$752K	Buy	1,412 +1,147	+433%	+$823K	﹤0.01%	2957
2021 Q3	$71K	Buy	265 +178	+205%	+$76.3K	﹤0.01%	5919
2021 Q2	$78K	Buy	+87	New	+$66.5K	﹤0.01%	5504

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wolverine Trading's BIOR Position: Q4 2022 in Review

Wolverine Trading sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2022, closing a stake of 293 shares — an estimated $36K sold.

Wolverine Trading first reported a position in BIOR in Q3 2021 and held it in 4 quarters. The position peaked at $257K in Q4 2021. 42 funds tracked by Wall St. Rank hold BIOR as of Q4 2022.

Wolverine Trading reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Wolverine Trading sold 293 Biora Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $36K.
Wolverine Trading first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Wolverine Trading's Biora Therapeutics, Inc. Common Stock position peaked at $257K in Q4 2021.
42 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.